Cargando…
Comparison of the injection‐site experience of the starting doses with semaglutide and dulaglutide: A randomized, double‐blind trial in healthy subjects
This double‐blind, randomized, single‐site, crossover trial compared the injection‐site experience with the starting doses of semaglutide and dulaglutide. Healthy subjects (aged 18–75 years; body mass index ≥ 25 kg/m(2); n = 104) were randomized 1:1, using a pregenerated list, to semaglutide 0.25 mg...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251561/ https://www.ncbi.nlm.nih.gov/pubmed/33591618 http://dx.doi.org/10.1111/dom.14349 |